ongo
outbreak
coronaviru
diseas
infect
patient
within
beyond
epidem
area
wuhan
china
show
differ
epidemiolog
clinic
characterist
pauciti
data
concern
coinfect
common
respiratori
pathogen
patient
outsid
wuhan
conduct
doublecentr
studi
recruit
patient
sever
acut
respiratori
coronaviru
infect
confirm
nucleic
acid
test
qingdao
wuhan
januari
februari
indirect
immunofluoresc
perform
detect
specif
igm
antibodi
common
respiratori
pathogen
collect
acut
phase
serum
patient
infect
qingdao
median
age
qingdao
wuhan
patient
iqr
iqr
year
respect
major
patient
femal
qingdao
wuhan
among
patient
qingdao
igm
antibodi
least
one
respiratori
pathogen
wherea
one
patient
wuhan
posit
result
serum
igm
antibodi
detect
p
common
respiratori
pathogen
detect
qingdao
patient
influenza
viru
influenza
viru
b
follow
mycoplasma
pneumonia
legionella
pneumophila
pattern
coinfect
patient
communityacquir
pneumonia
qingdao
quit
differ
posit
rate
interpret
report
larg
proport
patient
coinfect
season
respiratori
pathogen
qingdao
northeast
china
differ
greatli
patient
wuhan
central
china
precaut
need
deal
patient
beyond
epidem
centr
coinfect
respiratori
pathogen
highli
recommend
ad
routin
diagnost
test
capabl
hospit
prevent
misdetect
viru
begin
decemb
cluster
pneumonia
unknown
aetiolog
emerg
wuhan
hubei
provinc
china
diseas
soon
develop
outbreak
pose
pandem
threat
sinc
caus
pathogen
identifi
onset
diseas
call
wuhan
pneumonia
health
offici
public
decemb
total
case
report
meanwhil
rapid
respons
team
led
chines
centr
diseas
control
prevent
china
cdc
form
conduct
detail
epidemiolog
aetiolog
investig
wuhan
laboratori
qingdao
wuhan
adopt
similar
protocol
detect
igm
raw
data
enter
two
person
doubl
data
entri
awar
arrang
studi
group
continu
variabl
nonnorm
distribut
express
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
median
interquartil
rang
iqr
compar
mannwhitney
u
test
categor
variabl
present
number
compar
test
fisher
exact
test
wuhan
qingdao
group
twosid
less
consid
statist
signific
statist
analys
done
use
sa
softwar
version
februari
total
patient
laboratoryconfirm
infect
includ
final
analysi
among
qingdao
wuhan
tabl
patient
respiratori
specimen
test
specif
igm
antibodi
ifva
ifvb
rsv
adv
piv
mp
lp
cp
cox
among
patient
admit
qingdao
patient
igm
antibodi
detect
least
one
abovement
pathogen
overal
posit
rate
tabl
wherea
one
patient
wuhan
posit
result
respiratori
pathogen
common
respiratori
virus
detect
ifva
ifvb
follow
mp
lp
age
healthi
control
group
rang
year
median
age
year
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
iqr
men
peopl
group
specificigm
antibodi
detect
serum
suggest
asymptomat
infect
singl
viru
ifvb
total
infect
rate
healthi
control
significantli
lower
patient
p
tabl
none
individu
control
group
show
evid
combin
infect
two
pathogen
climat
characterist
qingdao
wuhan
decemb
januari
follow
year
shown
tabl
differ
could
observ
two
citi
although
climat
qingdao
drier
colder
wuhan
major
respiratori
pathogen
circul
two
citi
quit
similar
extend
descript
studi
patient
wuhan
qingdao
repres
within
beyond
epidem
centr
respect
sinc
earli
onset
till
specif
definit
novel
coronaviru
previous
known
releas
januari
term
illnesspneumonia
unknown
aetiolog
repeatedli
quot
health
offici
public
onemonth
period
one
possibl
explan
failur
clearli
defin
diseas
caus
pathogen
could
found
earli
stage
specul
common
respiratori
pathogen
influenza
parainfluenza
virus
rsv
adv
mp
cp
previou
emerg
novel
coronavirus
includ
sarscov
merscov
isol
bodi
fluid
secret
infect
patient
relat
treatment
manag
could
implement
first
place
unlik
pneumonia
unknown
caus
would
still
emphas
although
might
caus
delay
discoveri
therefor
assum
possibl
coinfect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patient
rare
assumpt
led
support
two
recent
studi
conduct
wuhan
show
coinfect
respiratori
pathogen
case
accord
data
major
patient
qingdao
endem
area
infect
indirectli
without
histori
travel
wuhan
despit
high
coinfect
rate
qingdao
patient
complic
clinic
condit
also
compar
geograph
climat
characterist
qingdao
wuhan
wuhan
locat
centr
southern
china
subtrop
climat
qingdao
situat
coastal
area
northern
china
temper
zone
rel
lower
humid
wuhan
despit
differ
natur
characterist
two
citi
common
respiratori
pathogen
circul
wuhan
qingdao
includ
ifva
ifvb
rsv
adv
shown
gener
similar
peak
season
respiratori
diseas
wintertim
januari
februari
incid
coinfect
patient
wuhan
rather
low
wherea
place
rel
low
temperatur
like
northern
qingdao
common
find
combin
infect
season
respiratori
pathogen
yet
known
whether
phenomenon
also
exist
region
leav
gap
futur
studi
limit
data
address
whether
coinfect
respiratori
pathogen
would
affect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
pathogenesi
outcom
sever
acut
respiratori
ill
like
sar
mer
fortun
rna
detect
patient
respiratori
pathogen
detect
otherwis
covid
notabl
sever
limit
studi
two
critic
ill
patient
one
patient
die
end
exclud
due
lack
aetiolog
data
februari
case
confirm
infect
qingdao
howev
analys
nonsever
case
whose
complet
aetiolog
clinic
inform
avail
age
patient
qingdao
rang
year
year
wherea
patient
wuhan
adult
medic
profession
infect
work
age
differ
two
group
might
bring
bia
studi
perform
nucleic
acid
test
confirm
infect
coinfect
pathogen
detect
serolog
test
antibodi
spite
superior
accuraci
pcrbase
molecular
test
use
throat
swab
requir
complic
techniqu
laboratori
personnel
prolong
report
time
may
suitabl
emerg
case
thu
appli
rapid
test
aetiolog
agent
iif
collect
acut
phase
serum
guid
clinic
decis
make
sinc
hospit
qingdao
wuhan
adopt
protocol
diagnosi
coinfect
believ
affect
determin
final
outcom
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
test
reliabl
serum
specif
igm
detect
recruit
control
group
normal
peopl
without
clinic
symptom
low
infect
rate
control
popul
suggest
method
reliabl
earli
rapid
diagnosi
respiratori
infect
howev
unabl
exclud
possibl
coinfect
respiratori
pathogen
may
make
patient
suscept
infect
specificigm
antibodi
could
detect
serum
one
week
ill
onward
amount
progress
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
data
express
n
median
iqr
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
data
express
n
median
iqr
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
